Dihydropyridine calcium channel blockers in the elderly with diabetic nephropathy: Are they safe?
作者信息
Khitan Zeid J, Tzamaloukas Antonios H, Brodsky Sergey, Shapiro Joseph I
机构信息
Joan C. Edwards School of Medicine at Marshall University, Huntington, WV, USA.
University of New Mexico School of Medicine, Albuquerque, NM, USA.
出版信息
J Clin Hypertens (Greenwich). 2018 Jan;20(1):203-204. doi: 10.1111/jch.13158. Epub 2018 Jan 6.
Abstract
摘要
相似文献
1
Dihydropyridine calcium channel blockers in the elderly with diabetic nephropathy: Are they safe?老年糖尿病肾病患者使用二氢吡啶类钙通道阻滞剂：它们安全吗？
J Clin Hypertens (Greenwich). 2018 Jan;20(1):203-204. doi: 10.1111/jch.13158. Epub 2018 Jan 6.
2
[Molecular Mechanism of Dihydropyridine Ca Channel Blockers in Pulmonary Hypertension].[二氢吡啶类钙通道阻滞剂治疗肺动脉高压的分子机制]
Yakugaku Zasshi. 2016;136(10):1373-1377. doi: 10.1248/yakushi.16-00086.
3
A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity.一些已上市的二氢吡啶类钙通道阻滞剂具有盐皮质激素受体拮抗剂活性。
Hypertension. 2008 Mar;51(3):742-8. doi: 10.1161/HYPERTENSIONAHA.107.103580. Epub 2008 Feb 4.
4
Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.长效和中效二氢吡啶类钙通道阻滞剂治疗高血压的效果：18项前瞻性、随机、阳性对照试验的系统评价和荟萃分析
J Cardiovasc Pharmacol Ther. 2018 Sep;23(5):433-445. doi: 10.1177/1074248418771341. Epub 2018 May 8.
5
Effect of the two new calcium channel blockers mebudipine and dibudipine in comparison to amlodipine on vascular flow of isolated kidney of diabetic rat.
Acta Physiol Hung. 2010 Sep;97(3):281-9. doi: 10.1556/APhysiol.97.2010.3.4.
6
High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.针对1,4 - 二氢吡啶类钙离子通道阻滞剂的高亲和力抗体。
Proc Natl Acad Sci U S A. 1986 May;83(9):2792-6. doi: 10.1073/pnas.83.9.2792.
7
8
Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN).二氢吡啶类钙通道阻滞剂、血管紧张素转换酶抑制剂及血压控制对慢性非糖尿病性肾病的影响。意大利肾脏病流行病学研究组（GISEN）。
J Am Soc Nephrol. 1998 Nov;9(11):2096-101. doi: 10.1681/ASN.V9112096.
9
Treating hypertension in the diabetic patient: therapeutic goals and the role of calcium channel blockers.糖尿病患者的高血压治疗：治疗目标及钙通道阻滞剂的作用
Clin Ther. 1993 Jul-Aug;15(4):618-36; discussion 617.
10
Combinatorial synthesis and screening of a chemical library of 1,4-dihydropyridine calcium channel blockers.
Bioorg Med Chem. 1998 Jul;6(7):883-9. doi: 10.1016/s0968-0896(98)00048-0.
引用本文的文献
1
Let‑7a‑5p may participate in the pathogenesis of diabetic nephropathy through targeting HMGA2.Let-7a-5p 可能通过靶向 HMGA2 参与糖尿病肾病的发病机制。
Mol Med Rep. 2019 May;19(5):4229-4237. doi: 10.3892/mmr.2019.10057. Epub 2019 Mar 19.
本文引用的文献
1
Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble.35个工业化国家的未来预期寿命：基于贝叶斯模型集成的预测
Lancet. 2017 Apr 1;389(10076):1323-1335. doi: 10.1016/S0140-6736(16)32381-9. Epub 2017 Feb 22.
2
Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.钙通道阻滞剂和肾素-血管紧张素系统抑制剂对慢性肾脏病患者肾脏结局及死亡率的影响：系统评价与荟萃分析
Ren Fail. 2016 Jul;38(6):849-56. doi: 10.3109/0886022X.2016.1165065. Epub 2016 Apr 7.
3
Effects of T-type calcium channel blockers on renal function and aldosterone in patients with hypertension: a systematic review and meta-analysis.T型钙通道阻滞剂对高血压患者肾功能和醛固酮的影响：一项系统评价和荟萃分析
PLoS One. 2014 Oct 17;9(10):e109834. doi: 10.1371/journal.pone.0109834. eCollection 2014.
4
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.贝那普利联合氨氯地平或氢氯噻嗪用于高危患者高血压的治疗
N Engl J Med. 2008 Dec 4;359(23):2417-28. doi: 10.1056/NEJMoa0806182.
5
Treatment of hypertension in patients 80 years of age or older.80岁及以上患者的高血压治疗
N Engl J Med. 2008 May 1;358(18):1887-98. doi: 10.1056/NEJMoa0801369. Epub 2008 Mar 31.
6
Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension.晚期原发性高血压患者肾自动调节功能受损的形态学证据。
Kidney Int. 2006 Mar;69(5):823-31. doi: 10.1038/sj.ki.5000163.
7
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).血管紧张素转换酶抑制剂或钙通道阻滞剂与利尿剂治疗高危高血压患者的肾脏转归：抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）报告
Arch Intern Med. 2005 Apr 25;165(8):936-46. doi: 10.1001/archinte.165.8.936.
8
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.氯沙坦对2型糖尿病肾病患者肾脏和心血管结局的影响。
N Engl J Med. 2001 Sep 20;345(12):861-9. doi: 10.1056/NEJMoa011161.
9
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.血管紧张素受体拮抗剂厄贝沙坦对2型糖尿病肾病患者的肾脏保护作用。
N Engl J Med. 2001 Sep 20;345(12):851-60. doi: 10.1056/NEJMoa011303.
10
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.雷米普利与氨氯地平对高血压性肾硬化症肾脏结局的影响：一项随机对照试验。
JAMA. 2001 Jun 6;285(21):2719-28. doi: 10.1001/jama.285.21.2719.
Zotero 插件